Crown Laboratories Acquires Bellus Medical, Completes Commercial Integration Plan

January 21, 2020

Crown Laboratories has announced that it has restructured its commercial operations business units as it continues to elevate its new “Skin Science for Life” commitment. For the past two years, Crown has been dedicated to transforming its Northeast Tennessee operations into a leading global skin care company. After acquiring its Beauty and Aesthetic divisions (formerly Vita Liberata and Bellus Medical, respectively) and strengthening its therapeutics portfolio through the acquisition of six consumer heritage brands from GlaxoSmithKline, Crown is now poised to become a global leader in dermatology health and wellness.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Federal Bill Would Establish New Ownership and Management Requirements for Medical Practices
    • CBS News Investigation Raises Concerns About Unapproved Retatrutide Sales
    • FDA Approves Belotero Volume and Belotero Intense
    • Ad IntellX Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • SafeLink Consulting Inc. Launches SafeLink360, Bringing Risk & Compliance Management and Expert Support Together in One Platform